203 related articles for article (PubMed ID: 14627174)
1. Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months.
Rosenhall L; Borg S; Andersson F; Ericsson K
Int J Clin Pract; 2003 Oct; 57(8):662-7. PubMed ID: 14627174
[TBL] [Abstract][Full Text] [Related]
2. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
[TBL] [Abstract][Full Text] [Related]
3. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
5. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma.
Rosenhall L; Elvstrand A; Tilling B; Vinge I; Jemsby P; Ståhl E; Jerre F; Bergqvist PB
Respir Med; 2003 Jun; 97(6):702-8. PubMed ID: 12814158
[TBL] [Abstract][Full Text] [Related]
6. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
Quirce S; Barcina C; Plaza V; Calvo E; Muñoz M; Ampudia R; Capel M
J Asthma; 2011 Oct; 48(8):839-47. PubMed ID: 21942354
[TBL] [Abstract][Full Text] [Related]
7. Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.
Brüggenjürgen B; Selim D; Kardos P; Richter K; Vogelmeier C; Roll S; Meyer-Sabellek W; Buhl R; Willich SN
Pharmacoeconomics; 2005; 23(7):723-31. PubMed ID: 15987228
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study.
Ige OM; Ohaju-Obodo JO; Chukwu C; Peters EJ; Okpapi J; Chukwuka C
Afr J Med Med Sci; 2010 Sep; 39(3):165-72. PubMed ID: 21416785
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
Wickstrøm J; Dam N; Malmberg I; Hansen BB; Lange P
Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
[TBL] [Abstract][Full Text] [Related]
10. The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing.
Buhl R; Kardos P; Richter K; Meyer-Sabellek W; Brüggenjürgen B; Willich SN; Vogelmeier C
Curr Med Res Opin; 2004 Aug; 20(8):1209-20. PubMed ID: 15324523
[TBL] [Abstract][Full Text] [Related]
11. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
[TBL] [Abstract][Full Text] [Related]
12. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
13. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting.
Søes-Petersen U; Kava T; Dahle R; Lei Y; Dam N
Clin Respir J; 2011 Jul; 5(3):173-82. PubMed ID: 21679353
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
Chervinsky P; Baker J; Bensch G; Parasuraman B; Boggs R; Martin P; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
[TBL] [Abstract][Full Text] [Related]
15. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
Miller E; FitzGerald JM
Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
[TBL] [Abstract][Full Text] [Related]
16. Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma.
Rosenhall L; Heinig JH; Lindqvist A; Leegaard J; Ståhl E; Bergqvist PB
Int J Clin Pract; 2002; 56(6):427-33. PubMed ID: 12166540
[TBL] [Abstract][Full Text] [Related]
17. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
[TBL] [Abstract][Full Text] [Related]
19. Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.
Canonica GW; Castellani P; Cazzola M; Fabbri LM; Fogliani V; Mangrella M; Moretti A; Paggiaro P; Sanguinetti CM; Vignola AM;
Pulm Pharmacol Ther; 2004; 17(4):239-47. PubMed ID: 15219269
[TBL] [Abstract][Full Text] [Related]
20. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
